Wealthspire Advisors (New York)’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$427K Sell
6,001
-3,850
-39% -$304K ﹤0.01% 620
2025
Q4
$808K Buy
9,851
+3,230
+49% +$252K 0.01% 479
2025
Q3
$497K Buy
6,621
+166
+3% +$12.4K ﹤0.01% 537
2025
Q2
$478K Sell
6,455
-2
-0% -$139 ﹤0.01% 551
2025
Q1
$521K Buy
6,457
+545
+9% +$46.8K ﹤0.01% 503
2024
Q4
$462K Buy
5,912
+715
+14% +$60.8K ﹤0.01% 530
2024
Q3
$488K Sell
5,197
-28
-0.5% -$2.35K 0.01% 505
2024
Q2
$407K Sell
5,225
-148
-3% -$12.1K 0.01% 471
2024
Q1
$488K Buy
5,373
+147
+3% +$12.2K 0.01% 431
2023
Q4
$404K Buy
5,226
+18
+0.3% +$1.26K 0.01% 452
2023
Q3
$354K Buy
5,208
+819
+19% +$59.6K 0.01% 456
2023
Q2
$357K Sell
4,389
-352
-7% -$28.1K 0.01% 430
2023
Q1
$389K Buy
+4,741
New +$339K 0.01% 391

Other funds holding GEHC

Wealthspire Advisors (New York)'s GEHC Position: Q1 2026 in Review

Wealthspire Advisors (New York) reduced its GE HealthCare (GEHC) stake by 39% in Q1 2026, selling an estimated $304K and leaving 6,001 shares worth $427K. The position accounts for ﹤0.01% of the portfolio, ranked #620.

Wealthspire Advisors (New York) first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $808K in Q4 2025. 1,269 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Wealthspire Advisors (New York) held 6,001 shares of GE HealthCare worth $427K as of Q1 2026.
  • Wealthspire Advisors (New York) sold 3,850 GE HealthCare shares in Q1 2026, an estimated $304K.
  • GE HealthCare made up ﹤0.01% of Wealthspire Advisors (New York)'s portfolio in Q1 2026, its #620 holding.
  • Wealthspire Advisors (New York) first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • Wealthspire Advisors (New York)'s GE HealthCare position peaked at $808K in Q4 2025.
  • 1,269 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Wealthspire Advisors (New York)'s 13F filing for Q1 2026, filed 1 May 2026.